Literature DB >> 31130491

Social-cognitive theory variables as correlates of sedentary behavior in multiple sclerosis: Preliminary evidence.

Robert W Motl1, Jeffer E Sasaki2, Katie L Cederberg2, Brenda Jeng2.   

Abstract

BACKGROUND: Persons with multiple sclerosis(MS) engage in substantially more sedentary behavior than adults from the general population.
OBJECTIVE: Hypothesis: This preliminary, cross-sectional study examined social-cognitive theory(SCT) variables as correlates of sedentary behavior in MS. We hypothesized that scores from SCT variables for sedentary behavior change would correlate with scores from self-reported and device-measured volumes of sedentary behavior in MS. We further hypothesized that the correlations would be stronger for self-reported than device-measured sedentary behavior, and that the primary correlate of sedentary behavior would be self-efficacy.
METHODS: We recruited participants through a random sample of 1,000 persons enrolled in the North American Research Committee on MS registry, and 275 of the 296 persons who underwent screening volunteered for the study. Participants wore an ActiGraph accelerometer on a belt around the waist for measuring minutes per day of sedentary behavior. Participants further completed a newly-created, study-specific measure of SCT variables for reducing sedentary behavior(i.e., self-efficacy, outcome expectations, barriers, goal setting, & planning) and the abbreviated International Physical Activity Questionnaire as a self-report measure of sitting time.
RESULTS: Self-reported sedentary behavior was associated with self-efficacy(r = -0.47), goal setting(r = -0.31), planning(r = -0.35), and barriers(r = 0.39) for reducing sedentary behavior. Device-measured sedentary behavior was associated with self-efficacy(r = -0.32), goal setting(r = -0.21), planning(r = -0.18), and barriers(r = 0.20). Self-efficacy(β = -0.29), barriers(β = 0.26), and planning(β = -0.24) independently explained variance in self-reported sedentary behavior(R2 = 0.33). Only self-efficacy(β = -0.32) independently explained variance in device-measured sedentary behavior(R2 = 0.10).
CONCLUSION: SCT constructs might be reasonable targets of a behavioral intervention for reducing sedentary behavior in MS.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Multiple sclerosis; Sedentary behavior; Social-cognitive theory

Mesh:

Year:  2019        PMID: 31130491     DOI: 10.1016/j.dhjo.2019.05.002

Source DB:  PubMed          Journal:  Disabil Health J        ISSN: 1876-7583            Impact factor:   2.554


  5 in total

1.  Demographic, clinical, and symptomatic correlates of subjective sleep quality in adults with multiple sclerosis.

Authors:  Katie L J Cederberg; Brenda Jeng; Jeffer E Sasaki; E Morghen Sikes; Stephanie L Silveira; Gary Cutter; Robert W Motl
Journal:  Mult Scler Relat Disord       Date:  2021-08-08       Impact factor: 4.808

2.  Is Symptomatic Fatigue Associated With Physical Activity and Sedentary Behaviors Among Persons With Multiple Sclerosis?

Authors:  Whitney N Neal; Katie L Cederberg; Brenda Jeng; Jeffer E Sasaki; Robert W Motl
Journal:  Neurorehabil Neural Repair       Date:  2020-04-28       Impact factor: 3.919

3.  Physical activity and self-reported sleep quality in adults with multiple sclerosis.

Authors:  Katie L J Cederberg; Brenda Jeng; Jeffer E Sasaki; E Morghen Sikes; Gary Cutter; Robert W Motl
Journal:  Disabil Health J       Date:  2021-06-11       Impact factor: 4.615

4.  Physical Activity, Sedentary Behavior, and Barriers to Exercise in People Living With Dystonia.

Authors:  Alana McCambridge; Rebecca M Meiring; Lynley V Bradnam
Journal:  Front Neurol       Date:  2019-10-22       Impact factor: 4.003

5.  Patterns and correlates of sedentary behaviour among people with multiple sclerosis: a cross-sectional study.

Authors:  Jennifer Fortune; Meriel Norris; Andrea Stennett; Cherry Kilbride; Grace Lavelle; Wendy Hendrie; Christina Victor; Jennifer Mary Ryan
Journal:  Sci Rep       Date:  2021-10-13       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.